Cardio · Signals
10 signals tracked in Cardio
Live feed of every funding round, regulatory shift, research drop, product launch, and ecosystem move ingested into this beat.
- WeightWatchers integrates Zepbound vials via LillyDirect pharmacy for member accessThe Index EditorialApr 29, 2025
- AHA Circulation 2025 Go Red issue calls for mandatory sex-disaggregated cardiovascular dataThe Index EditorialFeb 1, 2025
- Calibrate's 4th annual results report: members achieve 19% avg weight loss over 3 years via GLP-1 + ILIThe Index EditorialJan 15, 2025
- FDA approves Zepbound (tirzepatide) as first drug for obstructive sleep apnea in adults with obesityThe Index EditorialDec 20, 2024
- Sep 12, 2024
- SELECT trial sex subgroup in JACC: semaglutide reduces MACE in both sexes; women face higher baseline riskThe Index EditorialAug 30, 2024
- STEP-HFpEF pooled sex analysis: semaglutide drives greater weight loss in women (-9.6%) vs men (-7.2%)The Index EditorialJun 26, 2024
- Hims & Hers launches compounded GLP-1 injections starting at $199/monthThe Index EditorialMay 20, 2024
- Veera Health (India's largest online PCOS clinic) crosses $9M+ total raised$9M+ totalSeedThe Index EditorialFeb 14, 2024
- Ro launches Ro Body Program — GLP-1 + lab testing + 1:1 coaching for obesity treatmentThe Index EditorialJan 23, 2023
As of Jun 13, 2026·10 primary citations· Verified Press coverage Source pending